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Abstract
Background: The functional integration of the neuro-, endocrine- and immune-systems suggests
that the transcriptome of white blood cells may reflect neuropsychiatric states, and be used as a
non-invasive diagnostic indicator. We used a mouse maternal separation model, a paradigm of early
adversity, to test the hypothesis that transcriptional changes in peripheral blood mononuclear cells
(PBMCs) are paralleled by specific gene expression changes in prefrontal cortex (PFC),
hippocampus (Hic) and hypothalamus (Hyp). Furthermore, we evaluated whether gene expression
profiles of PBMCs could be used to predict the separation status of individual animals.
Findings: Microarray gene expression profiles of all three brain regions provided substantial
evidence of stress-related neural differences between maternally separated and control animals.
For example, changes in expression of genes involved in the glutamatergic and GABAergic systems
were identified in the PFC and Hic, supporting a stress-related hyperglutamatergic state within the
separated group. The expression of 50 genes selected from the PBMC microarray data provided
sufficient information to predict treatment classes with 95% accuracy. Importantly, stress-related
transcriptome differences in PBMC populations were paralleled by stress-related gene expression
changes in CNS target tissues.
Conclusion: These results confirm that the transcriptional profiles of peripheral immune tissues
occur in parallel to changes in the brain and contain sufficient information for the efficient diagnostic
prediction of stress-related neural states in mice. Future studies will need to evaluate the relevance
of the predictor set of 50 genes within clinical settings, specifically within a context of stress-related
disorders.
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Background
The application of microarray techniques has provided
insights into the multi-dimensional molecular nature of
complex neuropsychiatric disorders. Studies have high-
lighted the value of using peripheral tissue targets [1,2], an
approach based on the functional integration of neural-,
endocrine- and immune-systems [3]. Regulatory
exchanges between components of these systems provide
a foundation for using peripheral tissue targets as indica-
tors of neuropsychiatric states.
One of the earliest demonstrations that gene expression
changes in peripheral blood mononucleoctyes (PBMCs)
reflected disease states in the brain, was based on a rat
model, where acute neural assaults resulted in gene
expression changes in PBMCs within 24 hours [4]. Recent
studies have focused on human neuropsychiatric disor-
ders with more subtle disruptions in neurophysiology.
Segman et al [1] were able to predict the onset and pro-
gression of post-traumatic stress disorder (PTSD), in
recently traumatised patients. Similarly, Tsuang et al [2]
showed that the microarray analysis of peripheral blood
samples discriminated between patients clinically diag-
nosed with schizophrenia or bipolar disorder and healthy
controls. Nevertheless, it remains to be established
whether gene expression changes in peripheral tissue tar-
gets are paralleled by specific transcriptional alterations in
neural tissues [1].
We have used the model of maternal separation, which is
known to induce long term alterations in neurophysiol-
ogy and stress-related behaviours in adult rodents [5,6] to
investigate i) whether parallel changes occur in gene
expression in three brain regions (the prefrontal cortex,
hippocampus, and hypothalamus) and PBMCs and ii)
whether gene expression changes in PBMCs could be used
to predict the animal treatment group.
Methods
Animals and treatment
Maternal separation was carried out on C57BL/6 mice as
previously described [6] with some modifications. Briefly,
MS litters were separated from dams for 3 h a day, starting
at 12 h 00 and ending at 15 h 00, from postnatal day
(PND) 1 to 14. SH animals underwent brief daily han-
dling. All subsequent procedures were carried out using
males only, as the consequences of separation are gender
specific [6].
Acute restraint stress, sacrifice, blood collection and brain 
dissections
Mice (NMS = 30, NSH = 30) were subjected to 10 min of
acute restraint stress and allowed to recover for 20 min
prior to sacrifice. Restraint stress was chosen as a means of
acutely activating the Hypothalamic-Pituitary-Adrenal
(HPA) axis (HPAA), which allowed for an assessment of
possible differences in plasma corticosterone profiles (van
Heerden et al, submitted manuscript). All mice were sac-
rificed, by means of cervical dislocation, immediately fol-
lowed by decapitation and collection of trunk blood.
Neural tissues: the (1) prefrontal cortex (PFC), (2) hip-
pocampus (Hic) and (3) hypothalamus (HYP) were
immediately dissected and submerged in RNALater® (Qia-
gen Inc., USA).
Microarray processing and data analysis
Fifty-five samples, 15× PFC (8× MS and 7× SH), 10× Hic
and 10× Hyp (5× MS and 5× SH, each and 20× PBMC
(10× MS and 10× SH) were used for microarray process-
ing, with a two-colour common reference design. Samples
were matched, so that 10 individuals (5× MS and 5× SH)
were completely represented in all tissues. A common ref-
erence pool was constructed by combining equal amounts
(0.75 μg) of PFC and Hic RNA from both groups. Com-
mercial pre-spotted, full mouse genome, microarray slides
(OpArray™) were sourced from Operon (Operon Biotech-
nologies, Germany). Full details of RNA labelling, micro-
array hybridization, image capture and microarray data
processing are given in Additional file 1: Supplementary
Methods. Microarray data are available in the ArrayEx-
press database http://www.ebi.ac.uk/arrayexpress under
accession number E-MEXP-2101.
Data normalization was done in R, using the Limma pack-
age [7]. Pre-processing and removal of batch effects were
done using GEPAS http://www.gepas.org and ASCA-genes
[8] respectively. Differentially expressed genes were iden-
tified using a concordance strategy [9], based on overlap
between three statistically divergent approaches. Genes
that had a P-value < 0.05, using both the Info statistic,
from the ScoreGenes software package http://
www.cs.huji.ac.il/labs/compbio/scoregenes/, and the
Tusher  et al [10] Significance Analysis of Microarrays
(SAM) implementation in the T-Rex module of GEPAS
http://www.gepas.org, in addition to an absolute fold-
change > 1.2 (where fold change is defined as the fold dif-
ference between MS and SH), were considered to be differ-
entially expressed (DE).
All data clustering was done in the Tigr MultiExperiment
Viewer V4.1 (TMEV, http://www.tm4.org) using a Pearson
correlation metric with average linkage. Functional
enrichment of GO terms within differentially expressed
gene sets was evaluated using Blast2GO [11]. Gene set
enrichment analysis on lists ordered according to SAM
statistics was done using FatiScan http://www.babe
lomics.org[12]. The PFC and Hyp lists were evaluated
using 50 partitions, the PBMC list using 55 partitions and
the Hic list using 60 partitions.BMC Research Notes 2009, 2:195 http://www.biomedcentral.com/1756-0500/2/195
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The efficiency of PBMC gene expression profiles at pre-
dicting the treatment class of samples (i.e. MS or SH) was
evaluated with the Prophet module in GEPAS http://
www.gepas.org[13] using both the K-nearest neighbour
(KNN) and Support Vector machine (SVM) algorithm
options. Leave-one-out cross validation was used to coun-
ter selection bias whilst simultaneously assessing predic-
tion efficacy.
Results and Discussion
Microarray data comparing the response of control and
MS adult mice to stress was used to investigate the pres-
ence of a functional link between gene expression changes
in the brain and PBMCs. In the first instance data was ana-
lysed to characterise the transcriptional response of three
brain regions, the prefrontal cortex, the hippocampus and
hypothalamus to stress, and to investigate whether a co-
ordinated change in glutamatergic and GABAergic systems
occurred in MS mice. Corresponding differences in gene
expression in PBMCs of MS mice compared to control
mice were also identified. Importantly, these differences
could be used to predict the treatment status of mice.
Microarray analysis
After normalization, replicate merging, removal of flagged
features and imputation, the number of genes expressed
in each tissue was: (1) PFC, 15 760; (2) Hic, 17 344; (3)
Hyp, 15 794 and (4) PBMC, 13 306.
MS produced gene expression differences in all tissues
Differentially expressed (DE) genes were identified in all
tissues (Figure 1A-D). A summary of all DE genes is pro-
vided in [see Additional file 2 Table S2], [see Additional
file 3 Table S3], [see Additional file 4 Table S4], and [see
Additional file 5 Table S5]. The unsupervised hierarchical
sample clustering of differentially expressed genes, pro-
duced clear group (MS or SH) separations within all tis-
sues (Figure 1E-H). No single gene was differentially
expressed across all tissues.
Gene set enrichment analysis revealed significant 
functional themes
The FatiScan analysis revealed the significant enrichment
of functional terms, in all tissues (Figure 2 and Figure 3).
In PBMC samples (Figure 3B), over-expressed terms could
be grouped, generally, into signalling- (GO:0004872,
GO:0051606, GO:0005887, GO:0007165,
GO:0007154), immune- (GO:0006955, GO:0006952,
GO:0005856, GO:0007275) and, interestingly, neurolog-
ically-related (GO:0008188, GO:0050877) classes. On
the other hand, under-expressed terms all displayed a
metabolic theme, with terms related to RNA and protein
processing (GO:0003735, GO:0016070, GO:0044267,
GO:0009058, GO:0009059, GO:0015031, GO:0006412,
GO:0005840, GO:0003676 and GO:0043021) and
energy metabolism (GO:0005739, GO:0051187 and
GO:0006099). These results suggest a functional shift in
the immune system in PBMCs in MS mice, characterised
by the coordinated down-regulation of energy requiring
processes, such as protein synthesis and transport. This
functional shift might reflect the well characterised mobi-
lisation of energy and inhibition of further storage in
response to stress [14].
Response of the glutamergic and GABergic systems in 
neural tissues after stress
DE genes and enriched functional terms from the PFC
datasets highlighted the importance of the glutamatergic
and GABAergic systems in the stress-related response of
the MS mice. These two neurotransmitter systems consti-
tute the major stimulatory (glutamate) and inhibitory
(GABA) mechanisms of neurotransmission, and work
counteractively to ensure optimal neuronal activity after
stress [15]. Glutamatergic signalling was enhanced in MS
mice possibly as a consequence of deficiencies in GABAer-
gic mediated inhibitory mechanisms.
DE genes whose products are involved in the modulation
of glutamatergic and GABAergic signalling included P2yr4
and Npvf (Figure 4). The activation of P2yr4 positively reg-
ulates glutamate release [16], whereas Npvf is an impor-
tant inhibitor of GABAergic neurotransmission [17]. The
over-expression of both these genes in the MS PFC tissue,
points to a hyperactive glutamatergic system. Supporting
this observation is the under-expression of Myo6 in the MS
samples. Myo6 is crucial for the efficient endocytosis of
postsynaptic glutamate receptors, with deficiencies result-
ing in increased excitatory neurotransmission [18]. Htr3a
was also under-expressed in MS samples. This receptor is
strongly associated with GABAergic neurons and interneu-
rons which activate the GABA mediated inhibitory neuro-
transmission in the prefrontal cortex [19]. The co-
ordinated under-expression of both pre- and post-synap-
tic component GO terms further supports the hypothesis
of a hyperglutamatergic state in the PFC of MS mice (Fig-
ure 4). Specifically, genes supporting depletion of postsy-
naptic components in MS mice included three GABAA
receptors (GABAA alpha-1 and -3, and GABAA gamma-3)
(Figure 4); such receptors mediate inhibition of neuro-
transmission with disruptions resulting in enhanced anx-
iety [20]. Genes supporting functional depletion of
presynaptic components included two metabotropic
glutamate receptors, mGluR3  and  mGluR7  (Figure 4).
These receptors participate in negative feedback mecha-
nisms that inhibit presynaptic glutamate release. Results
from the hippocampal gene expression dataset extend
these observations, with the over-representation, in MS
samples, of genes involved in ionotropic glutamate signal-
ling (Figure 4). Although this hyperglutamatergic theme
was not readily apparent in either the DE genes or func-BMC Research Notes 2009, 2:195 http://www.biomedcentral.com/1756-0500/2/195
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Differential gene expression results Figure 1
Differential gene expression results. Venn diagrams show the overlap between different gene selection criteria (Info and 
SAM P < 0.05 and Fold difference > 1.2) for (A) PBMC, (B) pFC, (C) Hic and (D) Hyp. This gene selection strategy significantly 
reduced the number of genes identified as DE by any one single criterion. Also shown are the false colour sample profiles of 
hierarchically clustered differentially expressed genes for (E) PBMC samples [347 over- and 71 under-expressed], and neural 
tissues (F) pFC [66 over- and 88 under-expressed], (G) Hic [71 over- and 75 under-expressed] and (H) Hyp [69 over- and 81 
under-expressed]. The selected genes produce a clear separation between MS and SH samples. Genes more highly expressed 
in MS samples are at the top and those more highly expressed in SH samples at the bottom. P = PBMC; F = pFC.BMC Research Notes 2009, 2:195 http://www.biomedcentral.com/1756-0500/2/195
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FatiScan gene set enrichment results Figure 2
FatiScan gene set enrichment results. Shown are significant co-ordinately expressed GO terms within whole gene sets 
for (A) PFC and (B) Hic. The normalized percentage of genes annotated with a specific term is indicated for each group. Red 
indicates coordinated over-expression in MS group and Blue coordinated over-expression SH group (or under-expression in 
MS group). Colour intensity denotes how strongly a term is over- or under-expressed.
FatiScan gene set enrichment results Figure 3
FatiScan gene set enrichment results. Shown are significant co-ordinately expressed GO terms within whole gene sets 
for (A) Hyp and (B) PBMC. The normalized percentage of genes annotated with a specific term is indicated for each group. Red 
indicates coordinated over-expression in MS group and Blue coordinated over-expression SH group (or under-expression in 
MS group). Colour intensity denotes how strongly a term is over- or under-expressed.BMC Research Notes 2009, 2:195 http://www.biomedcentral.com/1756-0500/2/195
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tionally enriched terms of the hypothalamus dataset,
under-expression of cortistatin may be relevant insofar as
cortistatin signalling inhibits glutamate induced
responses in hypothalamus [21] (Figure 4).
These findings are consistent with the central role of gluta-
mate in the stress-response, in structures such as PFC and
hippocampus. Stressors such as acute restraint have been
shown to produce dramatic and rapid increases in gluta-
mate levels primarily in the PFC, which ultimately culmi-
nates in HPAA activation and glucocorticoid secretion. In
addition, the hippocampus is a major site of stress-associ-
ated glutamate action. The mechanisms which regulate
glutamate action and release within this region function
downstream of prefrontal cortical processes, constituting
a secondary stress-response phase, which, unlike the PFC,
is sensitive to neuroendocrine modulation [22]. The
glutamatergic signature found here in both the PFC and
hippocampus is therefore consistent with previous work.
Functional significance of gene expression changes in 
PBMC tissues
A large number of genes (418) were found to be differen-
tially expressed between MS and SH individuals and
included several genes whose products are important
modulators of immune system function. Examples
include Foxp3, an essential modulator of T cell function
[23]; IL-17ra, the receptor target for the IL-17 mediated
inflammatory pathway [24]; and Ccl5  (also known as
Rantes), which regulates the activity of several cellular
populations within the immune system [25].
The evidence obtained from the neural transcriptomes
(combined with corticosterone and behavioural profiles;
van Heerden et al Submitted Manuscript) indicates that
pre-weaning treatment (MS or SH) result in differential
stress-related profiles. Given this context, the gene expres-
sion information derived from the PBMC samples was
evaluated in terms of its ability to derive accurate predic-
tions of pre-weaning status of individuals.
PBMC gene expression profiles accurately predict sample 
classes
The classification and prediction of sample classes (MS or
SH) using PBMC gene expression values, were found to be
highly efficient. Using KNN (with 4 neighbours), 50 genes
(Figure 5; Table 1) were sufficient to accurately identify
sample classes 19 out of 20 times. Most of the genes
included in the predictor were over-expressed (Figure 5B).
SVM, however, only achieved this success rate using a
minimum of 125 genes (with linear and radial kernels).
Importantly, this 125 gene set consisted of the 50 genes
included in Table 1, in addition to 75 other genes, which
were the same for both algorithms (data not shown).
Of the 50 genes included in the predictor, 46 were func-
tionally annotated. Of particular interest was the identifi-
cation of 3 genes, Oxt, Cck and Adcy8 (all over-expressed),
whose products are known to be important mediators of
stress- and anxiety-associated behaviours (Table 1) [26-
28]. Both Oxt and Cck are neuroactive hormones with
previously described endogenous immunomodulatory
properties [29,30]. These results confirm that the tran-
scriptional profiles of peripheral immune tissues do
indeed contain sufficient information for the efficient
diagnostic prediction of stress-related neural states in
mice. Products of these genes may participate in pathways
that are particularly sensitive to stress-induced regulation
of the immune system.
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Schematic summary of neural gene expression results in sup- port of a stress-related hyperglutamatergic state in MS brain  samples Figure 4
Schematic summary of neural gene expression 
results in support of a stress-related hyperglutama-
tergic state in MS brain samples. Such a hyperglutama-
terigc state could potentially result in elevated stress-induced 
corticosterone responses. Red indicates over-expression and 
blue under-expression, in MS samples, respectively. An aster-
isk indicates genes or functional classes that were found to 
be regulated in a coordinated manner. Glu = Glutamate, (+) 
indicates increased signalling activity, (-) indicates decreased 
signalling/acitivity.BMC Research Notes 2009, 2:195 http://www.biomedcentral.com/1756-0500/2/195
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Table 1: Summary of 50 gene predictor set, which classified samples with 95% accuracy*
Operon Oligo ID Description Symbol ENSEMBL/Refseq/Riken ID Over/Under expressed in MS
M400008627 RIKEN cDNA 4921528I07 gene 4921528I07Rik ENSMUSG00000074149 over
M200012683 Acetyl-Coenzyme A 
acetyltransferase 2
Acat2 ENSMUSG00000023832 over
M400004596 A disintegrin-like and 
metalloprotease with 
thrombospondin type 1 motif, 9
Adamts9 ENSMUSG00000030022 over
M200000582 Adenylate cyclase 8 Adcy8 ENSMUSG00000022376 over
M200005645 Actin related protein 2/3 complex, 
subunit 5-like
Arpc5l ENSMUSG00000026755 over
M200006901 ATPase, H+ transporting, lysosomal 
V0 subunit E2
Atp6v0e2 ENSMUSG00000039347 over
M400004024 cDNA sequence BC013672 BC013672 ENSMUSG00000037921 over
M400008030 Bone gamma-carboxyglutamate 
protein, related sequence 1
Bglap-rs1 ENSMUSG00000074489 over
M300011602 Carbonic anhydrase 14 Car14 ENSMUSG00000038526 over
M200000995 Cholecystokinins precursor Cck§ ENSMUSG00000032532 over
M200013753 Coronin 7 Coro7 ENSMUSG00000039637 over
M200003934 Cytochrome P450, family 2, 
subfamily c, polypeptide 29
Cyp2c29 ENSMUSG00000003053 over
M300013894 RIKEN cDNA D130054N24 gene D130054N24Rik ENSMUSG00000042790 over
M400003995 RIKEN cDNA D330050I23 gene D330050I23Rik ENSMUSG00000072569 over
M300010488 Dermokine Dmkn ENSMUSG00000060962 over
M200003607 Dedicator of cytokinesis 7 Dock7 ENSMUSG00000028556 over
M300014949 Endothelial differentiation, 
sphingolipid G-protein-coupled 
receptor, 5
Edg5 ENSMUSG00000043895 over
M400001692 Predicted gene EG620592 ENSMUSG00000071719 over
M400010593 Forkhead box protein R1 
(Forkhead box protein N5)
Foxr1 ENSMUSG00000074397 over
M300000132 Homeo box A4 Hoxa4 ENSMUSG00000000942 over
M400013298 LSM14 protein homolog A (Rap55) Lsm14a ENSMUSG00000066568 over
M400004821 Lysocardiolipin acyltransferase Lycat ENSMUSG00000054469 over
M400009939 Mitogen-activated protein kinase 
kinase kinase 9
Map3k9 ENSMUSG00000042724 over
M300007290 Mesoderm posterior 2 Mesp2 ENSMUSG00000030543 over
M200007123 Muted protein Muted§ ENSMUSG00000038982 under
M200010626 Matrix-remodelling associated 8 Mxra8 ENSMUSG00000073679 over
M200007448 Nitric oxide synthase interacting 
protein
Nosip ENSMUSG00000003421 over
M300018063 Olfactory receptor 1495 Olfr1495 ENSMUSG00000047207 over
M300017588 Olfactory receptor 66 Olfr66 ENSMUSG00000058200 over
M300015973 Olfactory receptor 669 Olfr669 ENSMUSG00000073916 over
M300002331 Predicted gene MGI:3652048 ENSMUSG00000020682 over
M200003458 Oxytocin Oxt ENSMUSG00000027301 over
M400010890 Mus musculus polymerase (RNA) II 
(DNA directed) polypeptide C
Polr2c ENSMUSG00000031783 over
M200000936 Peripherin 1 Prph1 ENSMUSG00000023484 over
M300003403 PTK2 protein tyrosine kinase 2 Ptk2 ENSMUSG00000022607 under
M400001722 Slingshot homolog 3 (Drosophila) Ssh3 ENSMUSG00000034616 over
M300003482 Type 2 lactosamine alpha-2,3-
sialyltransferase
St3gal6§ ENSMUSG00000022747 under
M200000227 Stromal interaction molecule 1 Stim1 ENSMUSG00000030987 over
M300001453 Surfeit gene 5 Surf5 ENSMUSG00000015776 over
M400000616 Thrombopoietin precursor Thpo ENSMUSG00000022847 over
M400009774 Transmembrane BAX inhibitor motif 
containing 1
Tmbim1 ENSMUSG00000006301 over
M200013582 Transmembrane protein 25 Tmem25 ENSMUSG00000002032 over
M400000938 Transmembrane protein 63A Tmem63a§ ENSMUSG00000026519 underBMC Research Notes 2009, 2:195 http://www.biomedcentral.com/1756-0500/2/195
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M400013169 Xin actin-binding repeat containing 2 
isoform 2
Xirp2 ENSMUSG00000027022 over
M400014435 Zinc finger protein 84 Zfp84 ENSMUSG00000046185 over
M400018008 Novel Protein Not assigned AC160535 over
M400012711 Novel protein (I830077J02Rik) Not assigned AC121847 over
M400017112 Uncharacterised Not assigned AK054246 over
M400003712 Uncharacterised Not assigned AC122270 over
M400008575 Uncharacterised Not assigned ENSMUSG00000064159 over
*Genes are sorted by gene symbol; § Not included in differentially expressed gene list
Table 1: Summary of 50 gene predictor set, which classified samples with 95% accuracy* (Continued)
Sample classification and prediction results Figure 5
Sample classification and prediction results. (A) Leave-one-out error rates of classifiers. The KNN algorithm (blue line) 
reaches an optimal prediction efficiency of 95% with a minimum of 50 genes. Using 125 genes the SVM algorithm (green line) 
obtains this efficiency, and converges with KNN. (B) Hierarchically sample clustered (Pearson correlation metric with average 
linkage) profiles for the 50 gene predictor set. Notice, that although only 19 out of 20 samples were correctly classified, hierar-
chical clustering separates all samples into two general treatment-related clusters. (C) A summary of KNN sample classification 
results, showing details of the misclassification of individual samples. Although most samples classes were correctly predicted, 
PBMC69, an SH sample, was consistently misclassified. P = PBMC.BMC Research Notes 2009, 2:195 http://www.biomedcentral.com/1756-0500/2/195
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